| Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels (NCT01811199) | Marmara University | 2011-02-01 |
| Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI (NCT01297231) | Memorial Sloan Kettering Cancer Center | 2011-02-01 |
| Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer (NCT01313039) | University of Miami | 2011-02-01 |
| Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction (NCT01310075) | M.D. Anderson Cancer Center | 2011-02-01 |
| A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer (NCT01201265) | Hoffmann-La Roche | 2011-02-01 |
| Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy (NCT01468766) | German Cancer Research Center | 2011-02-01 |
| Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy (NCT01612247) | University of Vermont | 2011-02-01 |
| Circadian Disturbances After Breast Cancer Surgery (NCT01171508) | Melissa Voigt Hansen | 2011-02-01 |
| MRI Evaluation of the Breast Areolar Margin and Paryenchyma (NCT01300585) | Piedmont Healthcare | 2011-02-01 |
| Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer (NCT01124695) | ECOG-ACRIN Cancer Research Group | 2011-01-07 |
| Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer (NCT01276041) | Memorial Sloan Kettering Cancer Center | 2011-01-05 |
| Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer (NCT01276704) | Carol Fabian, MD | 2011-01-01 |
| The Use of Metformin in Early Breast Cancer Patients Pre-Surgery (NCT01302002) | Instituto Nacional de Cancer, Brazil | 2011-01-01 |
| Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors (NCT02616744) | Azienda Ospedaliero-Universitaria Careggi | 2011-01-01 |
| Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07 (NCT01281137) | ETOP IBCSG Partners Foundation | 2011-01-01 |
| Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer (NCT01411943) | Virginia Commonwealth University | 2011-01-01 |
| Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer Survivors (NCT01414062) | Columbia University | 2011-01-01 |
| Knowledge and Attitudes of Patients and Healthcare Professionals on a Spectrum of Genetic Tests Relevant to Breast Cancer Patients (NCT01619306) | National University Hospital, Singapore | 2011-01-01 |
| Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer (NCT01273896) | Memorial Sloan Kettering Cancer Center | 2011-01-01 |
| Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer (NCT01278212) | University of Louisville | 2011-01-01 |
| Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) (NCT04031703) | Fudan University | 2011-01-01 |
| Assessment of Candidate Protein Expression in Breast Cancer Specimens (NCT00918892) | Case Comprehensive Cancer Center | 2011-01-01 |
| Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients (NCT01292408) | Radboud University Medical Center | 2011-01-01 |
| Radiotherapy After Primary Chemotherapy for Breastcancer (NCT01279304) | Maastricht Radiation Oncology | 2011-01-01 |
| Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC) (NCT01287624) | Fudan University | 2011-01-01 |
| Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer (NCT01300871) | University Health Network, Toronto | 2011-01-01 |
| Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients (NCT01446185) | Genomic Health®, Inc. | 2011-01-01 |
| Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer (NCT01301911) | Jiangsu HengRui Medicine Co., Ltd. | 2011-01-01 |
| Lifestyle, Exercise and Nutrition Study 1 (NCT02109068) | Yale University | 2011-01-01 |
| Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer (NCT01265654) | AstraZeneca | 2011-01-01 |
| Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer (NCT01308775) | University of California, San Francisco | 2011-01-01 |
| Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress (NCT01264562) | Ludwig-Maximilians - University of Munich | 2011-01-01 |
| Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer (NCT01048099) | SCRI Development Innovations, LLC | 2011-01-01 |
| Decisional Aid Intervention for Women Considering Breast Reconstruction (NCT01951534) | Rutgers, The State University of New Jersey | 2011-01-01 |
| Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction (NCT01649505) | OHSU Knight Cancer Institute | 2011-01-01 |
| Identification of New Prognostic Markers for Breast Cancer. (NCT03436069) | University Hospital, Grenoble | 2011-01-01 |
| Can Exercise Improve Cancer Associated Cognitive Dysfunction? (NCT01296893) | University of British Columbia | 2011-01-01 |
| Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors (NCT01225172) | Bristol-Myers Squibb | 2010-12-31 |
| Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer (NCT01247233) | UNICANCER | 2010-12-27 |
| Predictive Clinical and Biological Parameters in Breast Cancer (NCT01521676) | Institut Paoli-Calmettes | 2010-12-22 |
| Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014 (NCT01503034) | Centre Oscar Lambret | 2010-12-14 |
| Fast Food, Fatigue, and Inflammation (NCT04247763) | Ohio State University Comprehensive Cancer Center | 2010-12-13 |
| Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer (NCT01065441) | Michael Har-Noy | 2010-12-01 |
| A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer (NCT01256567) | Eli Lilly and Company | 2010-12-01 |
| Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer (NCT01254526) | Genentech, Inc. | 2010-12-01 |
| Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging (NCT01277263) | University of California, Irvine | 2010-12-01 |
| Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer (NCT01263613) | University of Wisconsin, Madison | 2010-12-01 |
| Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment (NCT01495650) | Institut du Cancer de Montpellier - Val d'Aurelle | 2010-12-01 |
| A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer (NCT01272141) | Emory University | 2010-12-01 |
| Delayed-Delayed Breast Reconstruction (NCT01256528) | M.D. Anderson Cancer Center | 2010-12-01 |
| Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy (NCT01163682) | Columbia University | 2010-12-01 |
| The Effects of Radiation in Reconstructed Breasts (NCT01292772) | Abramson Cancer Center at Penn Medicine | 2010-12-01 |
| Male Breast Cancer: Understanding the Biology for Improved Patient Care (NCT01101425) | European Organisation for Research and Treatment of Cancer - EORTC | 2010-12-01 |
| Using National University Cancer Institute of Singapore (NCIS) Registry to Measure Time Trends in Quality of Care for Breast Cancer Patients in a National Cancer Centre (NCT01866631) | National University Hospital, Singapore | 2010-12-01 |
| Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging (NCT01332916) | Centre Francois Baclesse | 2010-12-01 |
| Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer (NCT01199367) | Kyowa Kirin Co., Ltd. | 2010-12-01 |
| A Novel Therapy for the Treatment of Chest Wall Progression of Breast Cancer (NCT01262716) | Rogers Sciences Inc. | 2010-12-01 |
| Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging (NCT01257932) | University of California, Irvine | 2010-12-01 |
| Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer (NCT01269346) | Eisai Inc. | 2010-12-01 |
| Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients (NCT01305954) | UNC Lineberger Comprehensive Cancer Center | 2010-12-01 |
| Intervention Study of Depression in Breast Cancer Patients (NCT01256008) | Wenzhou Medical University | 2010-12-01 |
| PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer (NCT00816582) | British Columbia Cancer Agency | 2010-11-30 |
| AT13387 in Adults With Refractory Solid Tumors (NCT01246102) | National Cancer Institute (NCI) | 2010-11-19 |
| Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer (NCT01186367) | Memorial Sloan Kettering Cancer Center | 2010-11-11 |
| Trastuzumab and Vinorelbine in Advanced Breast Cancer (NCT01185509) | Dana-Farber Cancer Institute | 2010-11-01 |
| Breast Cancer Risk Biomarkers in Premenopausal Women (NCT01252277) | Carol Fabian, MD | 2010-11-01 |
| Effects of High Dose Calcitriol in Breast Cancer Patients (NCT01293682) | University of Rochester | 2010-11-01 |
| Cancer Mortality Affected by the Choice of Anesthetic Drugs? (NCT01418326) | Enlund | 2010-11-01 |
| Histology of Functional Density in Postmenopausal Breast (NCT01240278) | Mayo Clinic | 2010-11-01 |
| Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors (NCT01204801) | Medifocus, Inc. | 2010-11-01 |
| GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy (NCT01239251) | Memorial Sloan Kettering Cancer Center | 2010-11-01 |
| MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study (NCT01246856) | Radboud University Medical Center | 2010-11-01 |
| Redes III Patient Navigator Qol Study (NCT02275754) | The University of Texas Health Science Center at San Antonio | 2010-11-01 |
| Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer (NCT01036087) | M.D. Anderson Cancer Center | 2010-11-01 |
| Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast (NCT01249157) | Memorial Sloan Kettering Cancer Center | 2010-11-01 |
| Couplelinks.ca - An Online Intervention for Couples Affected by Breast Cancer (NCT01089764) | Canadian Breast Cancer Research Alliance | 2010-11-01 |
| Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast Cancer (NCT01242449) | Vejle Hospital | 2010-11-01 |
| Multiple Oncological Serial Scans Study (NCT01246726) | University Hospitals Bristol and Weston NHS Foundation Trust | 2010-11-01 |
| DIBH Proton Planning (NCT01386697) | Abramson Cancer Center at Penn Medicine | 2010-11-01 |
| Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer (NCT01277562) | City of Hope Medical Center | 2010-11-01 |
| The Clinical and Biochemical Effect of Therapeutic Massage on Fatigue and Insomnia in Women With Breast Cancer Receiving Radiation Therapy (NCT01071109) | Floyd Memorial Hospital and Health Services | 2010-11-01 |
| Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis (NCT01852032) | University of California, Davis | 2010-11-01 |
| Breast Cancer Risk Biomarkers in Postmenopausal Women (NCT01252290) | Carol Fabian, MD | 2010-11-01 |
| Clinical Trial to Evaluate the Safety and Efficacy of Breast Implant (NCT01711710) | Seoul National University Hospital | 2010-10-30 |
| Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer (NCT01138384) | NCIC Clinical Trials Group | 2010-10-27 |
| Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 (NCT01383135) | Stanford University | 2010-10-01 |
| Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer (NCT02031042) | Stockholm South General Hospital | 2010-10-01 |
| Participation Restrictions in Breast Cancer Survivors (NCT01225328) | Dartmouth-Hitchcock Medical Center | 2010-10-01 |
| Exploratory Study of Breast Cancer With ABY025 (NCT01216033) | Biomedical Radiation Sciences | 2010-10-01 |
| Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (NCT01764802) | Ohio State University Comprehensive Cancer Center | 2010-10-01 |
| A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients. (NCT01485926) | Cancer Trials Ireland | 2010-10-01 |
| Vitamin D, Diet and Activity Study (NCT01240213) | Fred Hutchinson Cancer Center | 2010-10-01 |
| PET/CT Evaluation of Treatment Response in Breast Cancer (NCT01222416) | Vanderbilt-Ingram Cancer Center | 2010-10-01 |
| A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer (NCT01196052) | Hoffmann-La Roche | 2010-10-01 |
| Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer (NCT01254136) | Incyte Corporation | 2010-10-01 |
| Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer (NCT01229605) | Tufts Medical Center | 2010-10-01 |
| Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer (NCT01008150) | NSABP Foundation Inc | 2010-10-01 |
| Vitamin D and Breast Cancer Biomarkers in Female Patients (NCT01224678) | Alliance for Clinical Trials in Oncology | 2010-10-01 |
| Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks (NCT01231204) | University of California, San Diego | 2010-10-01 |
| Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer (NCT01299038) | Beth Israel Deaconess Medical Center | 2010-10-01 |